Fineotex Chemical, 533333, FCL Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,998.34
49.03
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,960.36
0.87%
6.45

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

19.78
15.96
10.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.01
12.83
-2.58

PAT CAGR (%)

10 Years
5 Years
3 Years

15.47
14.54
-3.17

P:E (Median)

8 Years
5 Years
3 Years

29.34
34.53
33.01

P:BV (Average)

8 Years
5 Years
3 Years

5.43
7.03
5.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.69
24.74
22.90

Earnings Forecasts:

(Updated: 05-09-2026)

Description 2026 2027 2028 2029
Adj EPS 47 19 - -
P/E Ratio 1.10 2.71 - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 85.15 98.26 -13.34% 97.60 107.95 -9.59% 96.47 109.31 -11.75% 104.55 115.36 -9.37%
Expenses 69.45 81.26 -14.53% 78.35 87.79 -10.75% 74.56 79.67 -6.41% 81.43 85.65 -4.93%
EBITDA 15.70 16.99 -7.59% 19.25 20.15 -4.47% 21.91 29.63 -26.05% 23.11 29.71 -22.21%
EBIDTM 18.43% 17.30% 19.73% 18.67% 22.71% 27.11% 22.11% 25.75%
Other Income 10.78 9.97 8.12% 7.41 7.65 -3.14% 11.28 4.53 149.01% 12.43 11.06 12.39%
Interest 0.19 0.11 72.73% 0.17 0.21 -19.05% 0.12 0.17 -29.41% 0.13 0.11 18.18%
Depreciation 2.18 2.01 8.46% 2.13 1.86 14.52% 2.15 1.89 13.76% 2.10 1.74 20.69%
PBT 24.10 24.85 -3.02% 24.36 25.73 -5.32% 30.93 32.12 -3.70% 33.32 38.93 -14.41%
Tax 3.58 4.95 -27.68% 3.23 6.29 -48.65% 5.27 7.63 -30.93% 8.11 7.48 8.42%
PAT 20.52 19.89 3.17% 21.13 19.44 8.69% 25.65 24.49 4.74% 25.21 31.45 -19.84%
PATM 24.11% 20.25% 21.65% 18.01% 26.59% 22.40% 24.11% 27.26%
EPS 0.18 0.17 5.88% 0.18 0.17 5.88% 0.22 0.21 4.76% 0.22 0.27 -18.52%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 376.63 137.07 174.77% 313.73 119.78 161.92% 183.71 125.92 45.89% 137.70 145.73 -5.51%
Expenses 317.48 111.88 183.77% 270.04 98.50 174.15% 148.88 91.63 62.48% 106.68 109.34 -2.43%
EBITDA 59.14 25.20 134.68% 43.69 21.29 105.21% 34.84 34.29 1.60% 31.02 36.39 -14.76%
EBIDTM 15.70% 18.38% 13.93% 17.77% 18.96% 27.23% 22.53% 24.97%
Other Income 10.09 9.14 10.39% 9.46 7.55 25.30% 6.75 4.99 35.27% 7.72 6.90 11.88%
Interest 0.10 0.16 -37.50% 0.63 0.40 57.50% 0.23 0.20 15.00% 0.34 0.22 54.55%
Depreciation 4.39 2.69 63.20% 4.40 2.01 118.91% 3.33 2.59 28.57% 3.01 2.37 27.00%
PBT 64.74 31.49 105.59% 48.12 26.42 82.13% 38.02 36.48 4.22% 35.39 40.70 -13.05%
Tax 16.54 6.47 155.64% 4.33 6.29 -31.16% 7.91 8.65 -8.55% 9.32 8.64 7.87%
PAT 48.20 25.03 92.57% 43.79 20.13 117.54% 30.11 27.83 8.19% 26.08 32.07 -18.68%
PATM 12.80% 18.26% 13.96% 16.81% 16.39% 22.10% 18.94% 22.00%
EPS 0.33 0.22 50.00% 0.27 0.17 58.82% 0.23 0.24 -4.17% 0.23 0.28 -17.86%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 383.77 396.88 439.22 418.93 295.55 250.08 129.48 128.85 112.64 90.06 74.66 Net Sales Growth -10.93% -9.64% 4.84% 41.75% 18.18% 93.14% 0.49% 14.39% 25.07% 20.63% Cost Of Goods Sold 231.60 234.02 256.58 236.19 170.14 139.36 65.38 69.46 58.52 44.84 37.10 Gross Profit 152.17 162.85 182.64 182.74 125.41 110.72 64.10 59.39 54.12 45.22 37.56 GP Margin 39.65% 41.03% 41.58% 43.62% 42.43% 44.27% 49.51% 46.09% 48.05% 50.21% 50.31% Total Expenditure 303.79 319.90 333.54 305.47 234.55 196.69 98.26 101.06 87.33 66.48 56.11 Power & Fuel Cost - 1.08 1.48 1.14 1.15 0.93 0.58 0.38 0.33 0.24 0.26 % Of Sales - 0.27% 0.34% 0.27% 0.39% 0.37% 0.45% 0.29% 0.29% 0.27% 0.35% Employee Cost - 24.02 21.10 18.23 15.64 11.50 6.96 6.92 5.94 4.62 3.38 % Of Sales - 6.05% 4.80% 4.35% 5.29% 4.60% 5.38% 5.37% 5.27% 5.13% 4.53% Manufacturing Exp. - 19.28 20.03 20.66 19.23 18.28 11.10 10.13 10.82 8.07 7.84 % Of Sales - 4.86% 4.56% 4.93% 6.51% 7.31% 8.57% 7.86% 9.61% 8.96% 10.50% General & Admin Exp. - 10.44 8.78 9.49 8.42 7.52 5.25 5.43 3.52 2.05 2.00 % Of Sales - 2.63% 2.00% 2.27% 2.85% 3.01% 4.05% 4.21% 3.12% 2.28% 2.68% Selling & Distn. Exp. - 22.20 22.62 16.24 17.12 17.32 7.05 7.11 6.40 4.92 4.23 % Of Sales - 5.59% 5.15% 3.88% 5.79% 6.93% 5.44% 5.52% 5.68% 5.46% 5.67% Miscellaneous Exp. - 8.86 2.95 3.52 2.85 1.79 1.94 1.61 1.79 1.72 4.23 % Of Sales - 2.23% 0.67% 0.84% 0.96% 0.72% 1.50% 1.25% 1.59% 1.91% 1.75% EBITDA 79.97 76.98 105.68 113.46 61.00 53.39 31.22 27.79 25.31 23.58 18.55 EBITDA Margin 20.84% 19.40% 24.06% 27.08% 20.64% 21.35% 24.11% 21.57% 22.47% 26.18% 24.85% Other Income 41.90 45.39 27.49 32.42 10.66 6.14 15.52 3.26 0.97 7.55 10.12 Interest 0.61 0.53 0.59 0.81 0.57 0.51 0.32 0.29 0.57 0.39 0.28 Depreciation 8.56 8.39 7.16 4.52 3.37 2.25 1.42 1.11 0.94 0.60 0.59 PBT 112.71 113.45 125.42 140.55 67.71 56.76 45.00 29.65 24.76 30.14 27.79 Tax 20.19 21.56 28.19 29.92 15.69 12.78 9.02 6.25 7.60 8.86 6.67 Tax Rate 17.91% 19.00% 22.48% 21.29% 23.17% 22.52% 20.04% 36.70% 30.49% 29.40% 24.00% PAT 92.51 91.89 97.23 110.63 52.02 43.98 35.99 10.78 17.32 21.28 21.12 PAT before Minority Interest 92.51 91.89 97.23 110.63 52.02 43.98 35.99 10.78 17.32 21.28 21.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 24.11% 23.15% 22.14% 26.41% 17.60% 17.59% 27.80% 8.37% 15.38% 23.63% 28.29% PAT Growth -2.90% -5.49% -12.11% 112.67% 18.28% 22.20% 233.86% -37.76% -18.61% 0.76% EPS 0.79 0.79 0.83 0.95 0.45 0.38 0.31 0.09 0.15 0.18 0.18

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,011.77 772.23 533.33 568.97 517.00 368.23 218.51 196.34 182.33 141.12 127.03 Net Sales Growth 91.44% 44.79% -6.26% 10.05% 40.40% 68.52% 11.29% 7.68% 29.20% 11.09% Cost Of Goods Sold 669.46 503.71 312.51 334.88 325.98 222.46 132.90 116.19 109.23 79.32 68.77 Gross Profit 342.31 268.51 220.82 234.08 191.02 145.78 85.61 80.14 73.10 61.80 58.26 GP Margin 33.83% 34.77% 41.40% 41.14% 36.95% 39.59% 39.18% 40.82% 40.09% 43.79% 45.86% Total Expenditure 843.08 642.03 406.11 420.59 404.40 297.02 177.94 161.55 147.88 111.14 97.55 Power & Fuel Cost - 2.77 2.15 1.75 1.58 1.08 0.67 0.51 0.47 0.39 0.44 % Of Sales - 0.36% 0.40% 0.31% 0.31% 0.29% 0.31% 0.26% 0.26% 0.28% 0.35% Employee Cost - 40.35 24.32 21.16 18.38 13.57 8.86 8.73 7.53 6.18 4.64 % Of Sales - 5.23% 4.56% 3.72% 3.56% 3.69% 4.05% 4.45% 4.13% 4.38% 3.65% Manufacturing Exp. - 24.63 20.72 21.24 19.91 19.08 11.75 11.05 11.73 9.07 8.67 % Of Sales - 3.19% 3.89% 3.73% 3.85% 5.18% 5.38% 5.63% 6.43% 6.43% 6.83% General & Admin Exp. - 20.07 13.84 15.76 13.07 14.26 8.98 10.94 7.08 4.76 5.78 % Of Sales - 2.60% 2.60% 2.77% 2.53% 3.87% 4.11% 5.57% 3.88% 3.37% 4.55% Selling & Distn. Exp. - 29.23 25.47 18.62 18.84 21.91 10.04 9.82 7.69 7.57 6.30 % Of Sales - 3.79% 4.78% 3.27% 3.64% 5.95% 4.59% 5.00% 4.22% 5.36% 4.96% Miscellaneous Exp. - 21.27 7.10 7.17 6.65 4.66 4.73 4.31 4.15 3.86 6.30 % Of Sales - 2.75% 1.33% 1.26% 1.29% 1.27% 2.16% 2.20% 2.28% 2.74% 2.32% EBITDA 168.69 130.20 127.22 148.38 112.60 71.21 40.57 34.79 34.45 29.98 29.48 EBITDA Margin 16.67% 16.86% 23.85% 26.08% 21.78% 19.34% 18.57% 17.72% 18.89% 21.24% 23.21% Other Income 34.02 37.63 24.31 16.54 7.30 5.52 17.49 1.61 0.85 5.17 9.75 Interest 1.30 1.36 1.07 1.33 0.82 0.92 0.72 0.63 0.83 0.57 0.39 Depreciation 15.13 13.42 9.22 6.02 4.28 2.51 1.47 1.17 1.00 0.65 0.63 PBT 186.27 153.03 141.24 157.57 114.80 73.29 55.86 34.60 33.47 33.92 38.21 Tax 38.10 28.02 32.03 36.54 25.24 16.40 11.31 7.65 9.30 9.95 9.14 Tax Rate 20.45% 18.31% 22.68% 23.19% 21.99% 22.38% 20.25% 34.82% 27.65% 29.33% 23.92% PAT 148.18 108.76 108.21 119.80 88.31 55.17 42.59 13.08 22.52 22.70 25.81 PAT before Minority Interest 122.32 125.02 109.21 121.02 89.55 56.89 44.56 14.31 24.33 23.97 29.07 Minority Interest -25.86 -16.26 -1.00 -1.22 -1.24 -1.72 -1.97 -1.23 -1.81 -1.27 -3.26 PAT Margin 14.65% 14.08% 20.29% 21.06% 17.08% 14.98% 19.49% 6.66% 12.35% 16.09% 20.32% PAT Growth 41.04% 0.51% -9.67% 35.66% 60.07% 29.54% 225.61% -41.92% -0.79% -12.05% EPS 1.27 0.93 0.93 1.03 0.76 0.47 0.37 0.11 0.19 0.19 0.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 754.29 629.34 358.14 269.59 221.76 181.11 147.52 138.43 121.11 102.04 Share Capital 116.45 22.91 22.15 22.15 22.15 22.15 22.26 22.26 22.26 22.26 Total Reserves 637.50 605.62 335.50 247.16 199.57 158.96 125.26 116.17 98.85 79.78 Non-Current Liabilities 8.91 7.74 4.56 2.98 1.94 1.24 0.00 0.78 0.48 -0.09 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.22 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.04 0.09 0.35 0.03 0.14 0.06 0.06 0.05 0.04 0.07 Current Liabilities 54.66 57.76 68.54 50.15 46.89 30.34 23.26 20.14 17.69 13.02 Trade Payables 42.41 54.17 59.16 39.44 41.46 23.84 17.89 14.97 11.35 11.06 Other Current Liabilities 11.70 3.22 3.79 3.09 3.31 2.85 2.42 3.08 1.69 0.81 Short Term Borrowings 0.00 0.05 5.19 7.28 1.88 3.41 2.74 1.98 4.42 1.07 Short Term Provisions 0.55 0.33 0.40 0.33 0.24 0.24 0.22 0.12 0.22 0.07 Total Liabilities 817.86 694.84 431.24 322.72 270.59 212.69 170.78 159.35 139.28 114.97 Net Block 129.85 122.85 85.69 76.79 63.34 48.10 29.28 24.69 17.98 16.33 Gross Block 158.64 144.24 100.40 87.08 70.26 52.76 32.52 26.82 19.17 16.92 Accumulated Depreciation 28.78 21.38 14.72 10.29 6.92 4.67 3.25 2.14 1.19 0.59 Non Current Assets 560.13 491.15 212.50 167.01 102.19 103.33 93.99 89.09 91.66 83.88 Capital Work in Progress 0.00 6.69 0.00 0.36 0.00 2.65 0.48 0.00 0.00 0.00 Non Current Investment 315.82 346.71 109.76 76.29 27.58 41.83 53.31 52.60 62.57 56.40 Long Term Loans & Adv. 114.46 14.90 13.02 8.55 7.18 6.80 6.99 7.89 7.20 7.35 Other Non Current Assets 0.00 0.00 0.10 1.07 0.15 0.17 0.14 0.13 0.13 0.02 Current Assets 250.52 196.48 211.53 148.50 161.19 102.16 69.59 63.05 40.40 31.08 Current Investments 27.05 0.00 38.76 0.00 0.00 0.86 8.50 4.94 1.56 0.00 Inventories 66.42 53.27 37.40 37.35 48.48 21.74 12.93 13.81 11.88 7.19 Sundry Debtors 101.38 96.53 108.70 73.12 75.15 57.92 39.08 34.51 22.18 19.97 Cash & Bank 17.58 26.36 21.40 32.63 23.73 11.21 2.45 2.41 2.15 1.95 Other Current Assets 38.10 3.19 3.26 1.67 13.84 10.43 6.63 7.38 2.63 1.97 Short Term Loans & Adv. 28.42 17.13 2.01 3.73 12.07 7.75 1.45 2.24 1.76 1.57 Net Current Assets 195.86 138.73 142.99 98.35 114.30 71.81 46.33 42.91 22.72 18.07 Total Assets 810.65 687.63 424.03 315.51 263.38 205.49 163.58 152.14 132.06 114.96

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 882.43 731.32 447.09 348.66 262.14 209.34 169.69 158.81 135.72 112.48 Share Capital 116.45 22.91 22.15 22.15 22.15 22.15 22.26 22.26 22.26 22.26 Total Reserves 765.64 707.60 424.45 326.23 239.95 187.19 147.43 136.55 113.46 90.22 Non-Current Liabilities 14.18 8.66 5.18 3.19 2.02 1.25 0.01 0.78 0.48 -0.07 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.22 0.00 Unsecured Loans 3.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.09 0.09 0.35 0.03 0.14 0.06 0.06 0.05 0.04 0.07 Current Liabilities 205.30 67.10 89.41 63.84 68.07 49.62 31.32 29.47 18.56 20.06 Trade Payables 160.93 56.75 72.81 47.36 58.77 36.84 23.38 20.90 10.86 15.48 Other Current Liabilities 36.48 9.76 10.94 8.84 7.17 9.22 4.85 6.31 3.05 3.44 Short Term Borrowings 4.38 0.22 5.19 7.28 1.88 3.41 2.84 1.98 4.42 1.07 Short Term Provisions 3.51 0.37 0.47 0.36 0.25 0.15 0.24 0.28 0.23 0.07 Total Liabilities 1,159.21 814.63 548.15 422.70 339.48 266.96 207.31 194.74 160.95 139.66 Net Block 277.76 178.69 137.13 94.94 80.10 55.62 36.82 32.19 25.36 23.40 Gross Block 355.00 204.96 154.68 106.56 87.48 60.49 40.27 34.48 26.64 25.76 Accumulated Depreciation 77.24 26.27 17.54 11.62 7.38 4.87 3.45 2.28 1.28 2.36 Non Current Assets 584.11 553.70 262.31 198.77 107.69 101.33 91.92 86.44 88.76 80.99 Capital Work in Progress 2.17 21.08 0.00 0.36 0.00 4.59 0.63 0.14 0.12 0.00 Non Current Investment 290.43 330.40 107.95 89.33 17.31 31.52 43.98 43.22 53.19 47.01 Long Term Loans & Adv. 11.39 21.43 12.97 8.85 6.19 5.64 6.57 6.98 6.17 6.78 Other Non Current Assets 2.35 2.10 0.32 1.35 0.15 0.17 0.14 0.13 0.13 0.02 Current Assets 567.90 253.73 278.64 216.73 224.60 158.42 108.18 101.09 64.98 58.67 Current Investments 27.05 0.00 38.76 0.00 0.00 0.86 8.50 4.94 1.56 0.00 Inventories 154.61 64.48 50.11 47.29 59.59 28.75 21.09 25.09 21.10 13.14 Sundry Debtors 290.29 115.86 138.82 101.40 110.89 82.67 53.85 49.13 27.92 29.25 Cash & Bank 46.18 41.70 39.92 59.57 38.06 33.91 17.93 14.74 8.01 13.12 Other Current Assets 49.78 4.25 3.67 3.14 16.06 12.23 6.82 7.19 6.39 3.17 Short Term Loans & Adv. 46.00 27.44 7.36 5.32 14.06 9.05 1.48 1.89 3.73 2.36 Net Current Assets 362.60 186.62 189.23 152.88 156.52 108.80 76.87 71.62 46.42 38.61 Total Assets 1,152.01 807.43 540.95 415.50 332.29 259.75 200.10 187.53 153.74 139.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -73.11 58.10 68.60 66.29 13.47 -0.83 22.21 3.44 9.12 10.56 PBT 113.45 125.42 140.55 67.71 56.76 45.00 17.03 24.93 30.14 27.79 Adjustment -26.17 -17.41 -25.20 -3.92 -1.58 -13.18 11.80 0.50 -6.31 -9.21 Changes in Working Capital -142.57 -26.58 -13.92 18.45 -28.19 -24.86 -0.52 -14.20 -6.28 -0.83 Cash after chg. in Working capital -55.29 81.43 101.43 82.24 26.99 6.96 28.32 11.22 17.56 17.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.82 -23.33 -32.83 -15.96 -13.52 -7.79 -6.11 -7.78 -8.44 -7.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 63.08 -257.04 -11.06 -68.58 7.10 -6.19 -17.51 3.67 -8.25 -5.01 Net Fixed Assets -7.71 -50.53 -12.96 -17.18 -14.85 -22.41 -6.18 -7.65 -2.25 -2.98 Net Investments 3.84 -198.19 -72.23 -48.71 15.11 19.12 -4.27 6.59 -7.73 -8.03 Others 66.95 -8.32 74.13 -2.69 6.84 -2.90 -7.06 4.73 1.73 6.00 Cash from Financing Activity 32.01 173.36 -22.85 -5.00 -3.84 -2.72 -2.06 -0.69 -2.40 -6.30 Net Cash Inflow / Outflow 21.98 -25.58 34.69 -7.29 16.74 -9.74 2.64 6.43 -1.53 -0.75 Opening Cash & Equivalents 16.31 42.01 7.34 14.63 -2.10 7.65 4.96 -1.42 0.12 1.88 Closing Cash & Equivalent 38.14 16.31 42.01 7.34 14.63 -2.10 7.65 4.96 -1.41 1.13

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity -23.81 69.33 97.04 107.27 13.38 9.20 28.36 12.02 6.34 19.12 PBT 153.03 141.24 157.57 114.80 73.29 55.86 21.96 33.63 33.92 38.21 Adjustment -2.74 -11.77 -7.54 0.90 -0.66 -13.25 13.73 0.79 -3.60 -7.65 Changes in Working Capital -150.68 -31.73 -14.06 17.93 -42.16 -23.77 0.64 -12.83 -14.80 -0.03 Cash after chg. in Working capital -0.39 97.74 135.96 133.63 30.47 18.84 36.33 21.59 15.52 30.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -23.42 -28.40 -38.92 -26.36 -17.09 -9.65 -7.98 -9.57 -9.18 -11.41 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 105.18 -272.51 -46.49 -101.84 -0.74 -6.53 -19.01 4.18 -9.41 -10.89 Net Fixed Assets -7.71 -50.53 -12.96 -17.18 -14.85 -22.41 -6.18 -7.65 -2.25 -2.98 Net Investments 3.84 -198.19 -72.23 -48.71 15.11 19.12 -4.27 6.59 -7.73 -8.03 Others 109.05 -23.79 38.70 -35.95 -1.00 -3.24 -8.56 5.24 0.57 0.12 Cash from Financing Activity -62.52 176.49 -23.91 -6.44 -5.66 -4.44 -3.88 -3.44 -3.62 -5.85 Net Cash Inflow / Outflow 18.85 -26.68 26.64 -1.01 6.97 -1.78 5.47 12.76 -6.69 2.39 Opening Cash & Equivalents 29.07 56.32 30.29 28.93 20.54 23.03 17.18 3.60 6.59 8.54 Closing Cash & Equivalent 56.12 29.07 56.32 30.29 28.93 20.54 23.03 17.18 3.60 7.67

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 6.47 5.49 3.23 24.32 20.02 16.35 13.25 12.44 10.88 9.17 ROA 12.15% 17.27% 29.35% 17.54% 18.20% 18.77% 6.53% 11.60% 16.74% 19.98% ROE 13.29% 19.72% 35.29% 21.19% 21.84% 21.90% 7.54% 13.35% 19.07% 22.75% ROCE 16.47% 25.39% 44.16% 27.29% 28.06% 27.07% 11.91% 19.14% 26.67% 29.58% Fixed Asset Turnover 2.62 3.59 4.47 3.76 4.07 3.04 4.34 4.90 5.09 5.31 Receivable days 91.01 85.28 79.21 91.56 97.11 136.73 104.24 91.87 83.74 87.07 Inventory Days 55.04 37.67 32.56 53.00 51.24 48.87 37.87 41.63 37.89 28.75 Payable days 75.31 80.61 76.19 86.78 85.52 116.49 62.92 57.98 64.60 70.42 Cash Conversion Cycle 70.73 42.34 35.58 57.77 62.83 69.11 79.19 75.51 57.03 45.40 Total Debt/Equity 0.00 0.00 0.01 0.03 0.01 0.02 0.02 0.02 0.04 0.01 Interest Cover 215.26 214.40 174.30 118.94 111.59 143.01 59.77 44.65 77.73 98.74

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 7.57 6.38 4.03 31.46 23.67 18.90 15.25 14.27 12.19 10.11 ROA 12.67% 16.03% 24.93% 23.50% 18.76% 18.79% 7.12% 13.68% 15.95% 22.94% ROE 15.50% 18.56% 30.45% 29.34% 24.13% 23.51% 8.71% 16.52% 19.31% 28.53% ROCE 19.04% 24.04% 39.32% 37.30% 31.12% 29.35% 13.54% 22.86% 27.16% 37.14% Fixed Asset Turnover 2.76 2.97 4.36 5.33 4.98 4.34 5.25 5.97 5.46 5.58 Receivable days 95.99 87.15 77.05 74.94 95.93 114.02 95.72 77.12 73.00 74.20 Inventory Days 51.78 39.21 31.24 37.73 43.79 41.63 42.92 46.22 43.71 33.42 Payable days 78.87 75.66 65.49 59.42 78.44 82.68 55.74 41.38 46.48 57.24 Cash Conversion Cycle 68.89 50.70 42.81 53.25 61.28 72.96 82.90 81.97 70.23 50.38 Total Debt/Equity 0.01 0.00 0.01 0.02 0.01 0.02 0.02 0.01 0.03 0.01 Interest Cover 113.37 133.14 119.35 140.91 80.38 78.16 35.85 41.37 60.58 98.77

Top Investors:

ashish kacholia

nippon life india trustee ltd-a/c nippon india small cap fund

suresh kumar agarwal

Annual Reports:

News Update:

Fineotex Chemical’s arm incorporates wholly-owned step-down subsidiary in USA
2nd Sep 2026, 15:49 PM

Fineotex Biotex HealthGuard FZE has incorporated a new wholly-owned step-down subsidiary named Fineotex Holdings Inc.
Read More
Fineotex Chemical - Quarterly Results
24th Jul 2026, 00:00 AM

Read More
Fineotex Chemical’s arm expands Texas capacity by 150 MM lbs/year
8th Jun 2026, 16:30 PM

The expansion has enhanced the company's ability to meet the growing demand for specialty chemicals across domestic and international markets
Read More

Fineotex Chemical Ltd.

Chemicals

BSE: 533333 | NSE: FCL

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Fineotex Chemical Ltd.

Chemicals

BSE: 533333 | NSE: FCL

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: